idecabtagene vicleucel
2seventy bio,bms
and an excellent #ims2022 bonus slide to show that prior bcma exposure with bcma car-t seems to be worse regardless of what type of exposure. obviously small n and many many more studies about this to come! 
Asst Professor @UWMedicine @fredhutch, s/p @UCSFCancer heme/onc ?? CAR-T training. #MMsm #TcellRx #cellphonesandcelltherapies ????

COI: https://t.co/3Uuojuio6R